Document 2751 DOCN M94A2751 TI NASBA HIV-1 RNA amplification compared to HIV-1 RNA-PCR on plasma or serum samples: a Belgian field evaluation. DT 9412 AU Vandamme AM; Van Dooren S; Kok W; Goubau P; Fransen K; Kievits T; Desmyter J; Rega Institute, Leuven-Belgium. SO Int Conf AIDS. 1994 Aug 7-12;10(1):233 (abstract no. PB0363). Unique Identifier : AIDSLINE ICA10/94369824 AB The presence of HIV-1 RNA in the plasma or serum of European and African patients was monitored using RNA-PCR and the new HIV-1 NASBA system involving an isothermal amplification. Identical RNA extraction procedures, provided by the NASBA system, were used for both methods. Both NASBA and RNA-PCR are more sensitive than p24 for the detection of HIV-1 free virus in blood: 18 of the 35 p24 tested seropositives were p24 negative while only 2 were negative for both NASBA and RNA-PCR (Table). The detection limit for HIV-1 RNA was slightly better for NASBA: in 8 microliters plasma or serum, 0.01 CCID50 of spiked HIV-IIIB was reported positive for NASBA but indeterminate (ID) for RNA-PCR. Two seronegative samples were NASBA and RNA-PCR positive or indeterminate. This was probably due to a sample carryover contamination, which can be avoided by more careful lab practises. There was no cross reactivity with HIV-2 or HTLV-I. The extraction method used allowed us to detect HIV-1 RNA equally well in plasma on heparine or on EDTA. TABULAR DATA, SEE ABSTRACT VOLUME. DE Belgium Comparative Study Gene Amplification/*GENETICS Human HIV Core Protein p24/BLOOD HIV Infections/*DIAGNOSIS/MICROBIOLOGY HIV Seronegativity HIV Seropositivity/DIAGNOSIS/MICROBIOLOGY HIV-1/*GENETICS Polymerase Chain Reaction/*METHODS Predictive Value of Tests RNA, Viral/*BLOOD/GENETICS MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).